GlassScriptPhysician profile
Dale Lane
NPI 1316178627
$2,321.74
in general payments reported to CMS, 2019-2025
10 companies · $393 in 2025
The $393 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.85 · 2021: $116 · 2022: $1,251 · 2023: $28.27 · 2024: $513 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624 · Education: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.04 |
| Education | $309.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,357.93 | 2019-2025 | |
| Stryker Corporation | $387.98 | 2024 | 7 X 23mm Citrelock Implant, Ortholoc 2 Lapifuse, Fixos |
| Biocomposites INC | $163.56 | 2025 | Stimulan |
| Zimmer Biomet Holdings, INC. | $116.42 | 2021 | |
| Arthrosurface Incorporated | $109.19 | 2025 | Toemate, Toe Motiontm, Hemicap |
| Abbott Laboratories | $98.64 | 2024 | Eterna |
| Integra Lifesciences Corporation | $31.58 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Anika Therapeutics, INC. | $28.27 | 2023 | Total Anika, Tactoset |
| Ethicon US, LLC | $17.00 | 2025 | Dermabond, Vistaseal, Stratafix |
| Lifenet Health | $11.17 | 2024 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.